LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

Home・Stock List・Boston Scientific Corp.

Boston Scientific Corp.

Closed

Sector Healthcare

74.8 0.9

Buy Sell

Overview

Share price change

24h

Current

Min

74.24

Max

75.67

Key metrics
By Trading Economics
Income	-12M 492M
Sales	135M 3.9B
P/E Sector Avg	64.01 79.786
EPS	0.56
Profit margin	12.746
Employees	48,000
EBITDA	-27M 981M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+11.16 upside

Dividends
By Dow Jones
Next Earnings	24 Oct 2024

Market Stats
By TradingEconomics
Market Cap	3B 115B
Previous open	73.9
Previous close	74.8

News Sentiment

By Acuity

32%

68%

69 / 369 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

74.1529 / 77.69 Support & Resistance

Boston Scientific Corp. Chart

Related News

18 Jun 2024, 13:23 UTC

Acquisitions, Mergers, Takeovers

Correction to Boston Scientific to Buy Silk Road Article

18 Jun 2024, 11:41 UTC

Major Market Movers

Acquisitions, Mergers, Takeovers

Silk Road Medical Shares Surge Premarket on Boston Scientific Deal

18 Jun 2024, 11:31 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific to Buy Silk Road Medical for About $1.26 Billion

24 Apr 2024, 11:01 UTC

Earnings

Boston Scientific Lifts 2024 Outlook After Strong 1Q

24 Jul 2024, 12:02 UTC

Earnings

Boston Scientific Earnings Beat; Medtech Giant Raises Guidance -- IBD

24 Jul 2024, 10:48 UTC

Earnings

Boston Scientific Profit Beats Estimates As Cardiovascular Sales Surge -- MarketWatch

24 Jul 2024, 10:47 UTC

Earnings

GE Vernova Delivers An Earnings Beat With First Results After Separation, Even As Revenue Misses -- MarketWatch

24 Jul 2024, 10:47 UTC

Earnings

Boston Scientific Earnings Beat, Guidance Raised; Medtech Giant Rises -- IBD

24 Jul 2024, 10:33 UTC

Earnings

Boston Scientific Sees 3Q Net Sales Growth of About 13%-15% >BSX

24 Jul 2024, 10:32 UTC

Earnings

Boston Scientific Sees FY Net Sales Growth of About 13.5%-14.5% >BSX

24 Jul 2024, 10:30 UTC

Earnings

Boston Scientific Sees FY EPS $1.34-EPS $1.38 >BSX

24 Jul 2024, 10:30 UTC

Earnings

Boston Scientific Sees FY Adj EPS $2.38-Adj EPS $2.42 >BSX

24 Jul 2024, 10:30 UTC

Earnings

Boston Scientific 2Q Adj EPS 62c >BSX

24 Jul 2024, 10:30 UTC

Earnings

Boston Scientific 2Q EPS 22c >BSX

24 Jul 2024, 10:30 UTC

Earnings

Boston Scientific Sees 3Q Adj EPS 57c-Adj EPS 59c >BSX

24 Jul 2024, 10:30 UTC

Earnings

Boston Scientific Sees 3Q EPS 36c-EPS 38c >BSX

24 Jul 2024, 10:30 UTC

Earnings

Boston Scientific 2Q Sales $4.12B >BSX

18 Jun 2024, 20:22 UTC

Acquisitions, Mergers, Takeovers

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18 Jun 2024, 14:25 UTC

Acquisitions, Mergers, Takeovers

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18 Jun 2024, 12:54 UTC

Acquisitions, Mergers, Takeovers

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18 Jun 2024, 11:33 UTC

Acquisitions, Mergers, Takeovers

Silk Road Medical Stock Soars. It's Being Acquired by Boston Scientific. -- Barrons.com

18 Jun 2024, 11:18 UTC

Acquisitions, Mergers, Takeovers

Silk Road Medical Stock Rallies On Boston Scientific Acquisition Deal -- MarketWatch

18 Jun 2024, 11:03 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific Sees Immaterial Impact to Adjusted EPS In 2024, 2025 >BSX

18 Jun 2024, 11:02 UTC

Acquisitions, Mergers, Takeovers

Silk Road Medical to Be Acquired for $27.50/Share; Closed Monday at $21.67 >SILK BSX

18 Jun 2024, 11:01 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific: Silk Road Medical Deal Reflects Enterprise Value of About $1.16 Billion >BSX SILK

18 Jun 2024, 11:01 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific To Buy Silk Road Medical for $27.50/Share >BSX SILK

18 Jun 2024, 11:00 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific Announces Agreement To Acquire Silk Road Medical, Inc. >BSX SILK

24 Apr 2024, 12:30 UTC

Peer Comparison

Price change

Boston Scientific Corp. Forecast

Price Target

By TipRanks

11.16% upside

12 Months Forecast

Average 86.44 USD 11.16%

High 95 USD

Low 78 USD

Based on 19 Wall Street analysts offering 12 month price targets forBoston Scientific Corp. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

19 ratings

Buy

Hold

Sell

Based on 19 analysts giving stock ratings to Boston Scientific Corp. - Dist in the past 3 months.

Technical Score

By Trading Central

74.1529 / 77.69Support & Resistance

Recent bearish events outweigh bullish events.

All events are bearish.

There is one bullish event.

Sentiment

By Acuity

69 / 369 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Boston Scientific Corp.

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by businesses such Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. It operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy and Urology and Pelvic Health businesses. Rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.